Robert Bain Thomas, Director at REVA Medical, Inc. (RVA.AX), bought 5,000 shares at $2.99 ($15K) on 2018-03-28, disclosed to the SEC on 2018-03-30.
Open-market purchase of $15k RVA.AX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |
| RVA | BUY | 2016-07-19 | $224K | — | Filing → |